Furthermore, a recent study of a rare nonsense mutation rs149847328 has demonstrated a decrease in GCKR protein expression in patients carrying the rs149847328 variant in comparison with NAFLD patients with the wild‐type allele [84]. This evidence concerns the gene GCKR and metabolic dysfunction-associated steatotic liver disease.